Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erectile dysfunction in heart failure patients.

Ernst R Schwarz1, Saurabh Rastogi, Vishal Kapur

  • 1Division of Cardiology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA. ernst.schwarz@cshs.org

Journal of the American College of Cardiology
|September 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study.

Atherosclerosis·2026
Same author

Intra-coronary imaging and transcriptomics of calcified nodules before and after intensive lipid-lowering therapy: a YELLOW III substudy.

European heart journal. Imaging methods and practice·2026
Same author

Impact of peripheral arterial disease and cerebrovascular disease on outcomes in patients undergoing PCI.

International journal of cardiology. Heart & vasculature·2026
Same author

Intracoronary Imaging and Transcriptomic Characteristics Before and After Maximum Lipid-Lowering Therapy: YELLOW-III Study of Evolocumab and Maximum Statin Therapy in Chronic Coronary Disease.

JACC. Cardiovascular imaging·2026
Same author

Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 Trial.

JACC. Heart failure·2025
Same author

Impact of left ventricular function on outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.

American heart journal·2025

Chronic heart failure and erectile dysfunction often coexist due to shared risk factors and unique physiological impacts. Standard heart failure treatments can worsen sexual dysfunction, potentially leading to treatment noncompliance.

Area of Science:

  • Cardiology
  • Urology
  • Internal Medicine

Background:

  • Heart failure (HF) and erectile dysfunction (ED) are highly prevalent and frequently comorbid conditions.
  • Shared risk factors for HF and ED include diabetes mellitus, hypertension, smoking, and dyslipidemia.
  • Physiological changes in HF contribute to both organic and psychological factors causing ED.

Purpose of the Study:

  • To review the unique aspects of erectile dysfunction (ED) specifically within the heart failure (HF) patient population.
  • To highlight the interplay between HF pathophysiology, its treatment, and the development of ED.
  • To inform clinicians about the challenges in managing ED in HF patients.

Main Methods:

  • This is a review article.
  • Literature search on the comorbidity of heart failure and erectile dysfunction.

Related Experiment Videos

  • Analysis of shared risk factors and treatment implications.

    • Main Results:

    • HF and ED share common risk factors like diabetes, hypertension, smoking, and dyslipidemia.
    • HF itself presents unique organic and psychological factors contributing to ED.
    • Standard HF therapies (beta-blockers, digoxin, diuretics) can cause or exacerbate sexual dysfunction.

    Conclusions:

    • Erectile dysfunction is a significant concern in patients with chronic heart failure.
    • Medication side effects from HF treatment can negatively impact sexual function and adherence.
    • Understanding these unique aspects is crucial for comprehensive patient care and management.